4-[[6-(5-aminopentylsulfonylamino)-1H-benzimidazol-2-yl]methyl]-N-[(2-methylphenyl)methyl]cyclohexane-1-carboxamide;5-(1,3-dioxoisoindol-2-yl)pentane-1-sulfonyl chloride;N-[(2-fluorophenyl)methyl]-4-[(6-methyl-1H-benzimidazol-2-yl)methyl]cyclohexane-1-carboxamide;1-(2-hydroperoxyethyl)-4-methylcyclohexane;4-methylbenzene-1,2-diamine;1-[4-[(6-methyl-1H-benzimidazol-2-yl)methyl]cyclohexyl]ethanone;uranium;vanadium

C97H129ClFN13O11S2UV — CID 158332714

IUPAC4-[[6-(5-aminopentylsulfonylamino)-1H-benzimidazol-2-yl]methyl]-N-[(2-methylphenyl)methyl]cyclohexane-1-carboxamide;5-(1,3-dioxoisoindol-2-yl)pentane-1-sulfonyl chloride;N-[(2-fluorophenyl)methyl]-4-[(6-methyl-1H-benzimidazol-2-yl)methyl]cyclohexane-1-carboxamide;1-(2-hydroperoxyethyl)-4-methylcyclohexane;4-methylbenzene-1,2-diamine;1-[4-[(6-methyl-1H-benzimidazol-2-yl)methyl]cyclohexyl]ethanone;uranium;vanadium
SMILESCC(=O)C1CCC(Cc2nc3ccc(C)cc3[nH]2)CC1.CC1CCC(CCOO)CC1.Cc1ccc(N)c(N)c1.Cc1ccc2nc(CC3CCC(C(=O)NCc4ccccc4F)CC3)[nH]c2c1.Cc1ccccc1CNC(=O)C1CCC(Cc2nc3ccc(NS(=O)(=O)CCCCCN)cc3[nH]2)CC1.O=C1c2ccccc2C(=O)N1CCCCCS(=O)(=O)Cl.[U].[V]
InChIInChI=1S/C28H39N5O3S.C23H26FN3O.C17H22N2O.C13H14ClNO4S.C9H18O2.C7H10N2.U.V/c1-20-7-3-4-8-23(20)19-30-28(34)22-11-9-21(10-12-22)17-27-31-25-14-13-24(18-26(25)32-27)33-37(35,36)16-6-2-5-15-29;1-15-6-11-20-21(12-15)27-22(26-20)13-16-7-9-17(10-8-16)23(28)25-14-18-4-2-3-5-19(18)24;1-11-3-8-15-16(9-11)19-17(18-15)10-13-4-6-14(7-5-13)12(2)20;14-20(18,19)9-5-1-4-8-15-12(16)10-6-2-3-7-11(10)13(15)17;1-8-2-4-9(5-3-8)6-7-11-10;1-5-2-3-6(8)7(9)4-5;;/h3-4,7-8,13-14,18,21-22,33H,2,5-6,9-12,15-17,19,29H2,1H3,(H,30,34)(H,31,32);2-6,11-12,16-17H,7-10,13-14H2,1H3,(H,25,28)(H,26,27);3,8-9,13-14H,4-7,10H2,1-2H3,(H,18,19);2-3,6-7H,1,4-5,8-9H2;8-10H,2-7H2,1H3;2-4H,8-9H2,1H3;;
InChIKeyGQEXLTRNYVQKPS-UHFFFAOYSA-N
MW2060.74 g/mol
LogP18.76
Rot. Bonds29

About 4-[[6-(5-aminopentylsulfonylamino)-1H-benzimidazol-2-yl]methyl]-N-[(2-methylphenyl)methyl]cyclohexane-1-carboxamide;5-(1,3-dioxoisoindol-2-yl)pentane-1-sulfonyl chloride;N-[(2-fluorophenyl)methyl]-4-[(6-methyl-1H-benzimidazol-2-yl)methyl]cyclohexane-1-carboxamide;1-(2-hydroperoxyethyl)-4-methylcyclohexane;4-methylbenzene-1,2-diamine;1-[4-[(6-methyl-1H-benzimidazol-2-yl)methyl]cyclohexyl]ethanone;uranium;vanadium

4-[[6-(5-aminopentylsulfonylamino)-1H-benzimidazol-2-yl]methyl]-N-[(2-methylphenyl)methyl]cyclohexane-1-carboxamide;5-(1,3-dioxoisoindol-2-yl)pentane-1-sulfonyl chloride;N-[(2-fluorophenyl)methyl]-4-[(6-methyl-1H-benzimidazol-2-yl)methyl]cyclohexane-1-carboxamide;1-(2-hydroperoxyethyl)-4-methylcyclohexane;4-methylbenzene-1,2-diamine;1-[4-[(6-methyl-1H-benzimidazol-2-yl)methyl]cyclohexyl]ethanone;uranium;vanadium (PubChem CID 158332714) has the molecular formula C97H129ClFN13O11S2UV and a molecular weight of 2060.74 g/mol. Its IUPAC name is 4-[[6-(5-aminopentylsulfonylamino)-1H-benzimidazol-2-yl]methyl]-N-[(2-methylphenyl)methyl]cyclohexane-1-carboxamide;5-(1,3-dioxoisoindol-2-yl)pentane-1-sulfonyl chloride;N-[(2-fluorophenyl)methyl]-4-[(6-methyl-1H-benzimidazol-2-yl)methyl]cyclohexane-1-carboxamide;1-(2-hydroperoxyethyl)-4-methylcyclohexane;4-methylbenzene-1,2-diamine;1-[4-[(6-methyl-1H-benzimidazol-2-yl)methyl]cyclohexyl]ethanone;uranium;vanadium.

Molecular Properties

Compound Name4-[[6-(5-aminopentylsulfonylamino)-1H-benzimidazol-2-yl]methyl]-N-[(2-methylphenyl)methyl]cyclohexane-1-carboxamide;5-(1,3-dioxoisoindol-2-yl)pentane-1-sulfonyl chloride;N-[(2-fluorophenyl)methyl]-4-[(6-methyl-1H-benzimidazol-2-yl)methyl]cyclohexane-1-carboxamide;1-(2-hydroperoxyethyl)-4-methylcyclohexane;4-methylbenzene-1,2-diamine;1-[4-[(6-methyl-1H-benzimidazol-2-yl)methyl]cyclohexyl]ethanone;uranium;vanadium
PubChem CID158332714
Molecular FormulaC97H129ClFN13O11S2UV
Molecular Weight2060.74 g/mol
Exact Mass2058.90
IUPAC Name4-[[6-(5-aminopentylsulfonylamino)-1H-benzimidazol-2-yl]methyl]-N-[(2-methylphenyl)methyl]cyclohexane-1-carboxamide;5-(1,3-dioxoisoindol-2-yl)pentane-1-sulfonyl chloride;N-[(2-fluorophenyl)methyl]-4-[(6-methyl-1H-benzimidazol-2-yl)methyl]cyclohexane-1-carboxamide;1-(2-hydroperoxyethyl)-4-methylcyclohexane;4-methylbenzene-1,2-diamine;1-[4-[(6-methyl-1H-benzimidazol-2-yl)methyl]cyclohexyl]ethanone;uranium;vanadium
SMILESCC(=O)C1CCC(Cc2nc3ccc(C)cc3[nH]2)CC1.CC1CCC(CCOO)CC1.Cc1ccc(N)c(N)c1.Cc1ccc2nc(CC3CCC(C(=O)NCc4ccccc4F)CC3)[nH]c2c1.Cc1ccccc1CNC(=O)C1CCC(Cc2nc3ccc(NS(=O)(=O)CCCCCN)cc3[nH]2)CC1.O=C1c2ccccc2C(=O)N1CCCCCS(=O)(=O)Cl.[U].[V]
InChIInChI=1S/C28H39N5O3S.C23H26FN3O.C17H22N2O.C13H14ClNO4S.C9H18O2.C7H10N2.U.V/c1-20-7-3-4-8-23(20)19-30-28(34)22-11-9-21(10-12-22)17-27-31-25-14-13-24(18-26(25)32-27)33-37(35,36)16-6-2-5-15-29;1-15-6-11-20-21(12-15)27-22(26-20)13-16-7-9-17(10-8-16)23(28)25-14-18-4-2-3-5-19(18)24;1-11-3-8-15-16(9-11)19-17(18-15)10-13-4-6-14(7-5-13)12(2)20;14-20(18,19)9-5-1-4-8-15-12(16)10-6-2-3-7-11(10)13(15)17;1-8-2-4-9(5-3-8)6-7-11-10;1-5-2-3-6(8)7(9)4-5;;/h3-4,7-8,13-14,18,21-22,33H,2,5-6,9-12,15-17,19,29H2,1H3,(H,30,34)(H,31,32);2-6,11-12,16-17H,7-10,13-14H2,1H3,(H,25,28)(H,26,27);3,8-9,13-14H,4-7,10H2,1-2H3,(H,18,19);2-3,6-7H,1,4-5,8-9H2;8-10H,2-7H2,1H3;2-4H,8-9H2,1H3;;
InChIKeyGQEXLTRNYVQKPS-UHFFFAOYSA-N
XLogP18.76
TPSA386.52 Ų
H-Bond Donors10
H-Bond Acceptors17
Rotatable Bonds29
Heavy Atoms127
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002060.74
LogP ≤ 518.76
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1017

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'aniline', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'peroxide', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze 4-[[6-(5-aminopentylsulfonylamino)-1H-benzimidazol-2-yl]methyl]-N-[(2-methylphenyl)methyl]cyclohexane-1-carboxamide;5-(1,3-dioxoisoindol-2-yl)pentane-1-sulfonyl chloride;N-[(2-fluorophenyl)methyl]-4-[(6-methyl-1H-benzimidazol-2-yl)methyl]cyclohexane-1-carboxamide;1-(2-hydroperoxyethyl)-4-methylcyclohexane;4-methylbenzene-1,2-diamine;1-[4-[(6-methyl-1H-benzimidazol-2-yl)methyl]cyclohexyl]ethanone;uranium;vanadium with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[[6-(5-aminopentylsulfonylamino)-1H-benzimidazol-2-yl]methyl]-N-[(2-methylphenyl)methyl]cyclohexane-1-carboxamide;5-(1,3-dioxoisoindol-2-yl)pentane-1-sulfonyl chloride;N-[(2-fluorophenyl)methyl]-4-[(6-methyl-1H-benzimidazol-2-yl)methyl]cyclohexane-1-carboxamide;1-(2-hydroperoxyethyl)-4-methylcyclohexane;4-methylbenzene-1,2-diamine;1-[4-[(6-methyl-1H-benzimidazol-2-yl)methyl]cyclohexyl]ethanone;uranium;vanadium?
The IUPAC name of 4-[[6-(5-aminopentylsulfonylamino)-1H-benzimidazol-2-yl]methyl]-N-[(2-methylphenyl)methyl]cyclohexane-1-carboxamide;5-(1,3-dioxoisoindol-2-yl)pentane-1-sulfonyl chloride;N-[(2-fluorophenyl)methyl]-4-[(6-methyl-1H-benzimidazol-2-yl)methyl]cyclohexane-1-carboxamide;1-(2-hydroperoxyethyl)-4-methylcyclohexane;4-methylbenzene-1,2-diamine;1-[4-[(6-methyl-1H-benzimidazol-2-yl)methyl]cyclohexyl]ethanone;uranium;vanadium (CID 158332714) is 4-[[6-(5-aminopentylsulfonylamino)-1H-benzimidazol-2-yl]methyl]-N-[(2-methylphenyl)methyl]cyclohexane-1-carboxamide;5-(1,3-dioxoisoindol-2-yl)pentane-1-sulfonyl chloride;N-[(2-fluorophenyl)methyl]-4-[(6-methyl-1H-benzimidazol-2-yl)methyl]cyclohexane-1-carboxamide;1-(2-hydroperoxyethyl)-4-methylcyclohexane;4-methylbenzene-1,2-diamine;1-[4-[(6-methyl-1H-benzimidazol-2-yl)methyl]cyclohexyl]ethanone;uranium;vanadium.
What is the SMILES notation for 4-[[6-(5-aminopentylsulfonylamino)-1H-benzimidazol-2-yl]methyl]-N-[(2-methylphenyl)methyl]cyclohexane-1-carboxamide;5-(1,3-dioxoisoindol-2-yl)pentane-1-sulfonyl chloride;N-[(2-fluorophenyl)methyl]-4-[(6-methyl-1H-benzimidazol-2-yl)methyl]cyclohexane-1-carboxamide;1-(2-hydroperoxyethyl)-4-methylcyclohexane;4-methylbenzene-1,2-diamine;1-[4-[(6-methyl-1H-benzimidazol-2-yl)methyl]cyclohexyl]ethanone;uranium;vanadium?
The canonical SMILES for 4-[[6-(5-aminopentylsulfonylamino)-1H-benzimidazol-2-yl]methyl]-N-[(2-methylphenyl)methyl]cyclohexane-1-carboxamide;5-(1,3-dioxoisoindol-2-yl)pentane-1-sulfonyl chloride;N-[(2-fluorophenyl)methyl]-4-[(6-methyl-1H-benzimidazol-2-yl)methyl]cyclohexane-1-carboxamide;1-(2-hydroperoxyethyl)-4-methylcyclohexane;4-methylbenzene-1,2-diamine;1-[4-[(6-methyl-1H-benzimidazol-2-yl)methyl]cyclohexyl]ethanone;uranium;vanadium is CC(=O)C1CCC(Cc2nc3ccc(C)cc3[nH]2)CC1.CC1CCC(CCOO)CC1.Cc1ccc(N)c(N)c1.Cc1ccc2nc(CC3CCC(C(=O)NCc4ccccc4F)CC3)[nH]c2c1.Cc1ccccc1CNC(=O)C1CCC(Cc2nc3ccc(NS(=O)(=O)CCCCCN)cc3[nH]2)CC1.O=C1c2ccccc2C(=O)N1CCCCCS(=O)(=O)Cl.[U].[V].
What is the InChIKey of 4-[[6-(5-aminopentylsulfonylamino)-1H-benzimidazol-2-yl]methyl]-N-[(2-methylphenyl)methyl]cyclohexane-1-carboxamide;5-(1,3-dioxoisoindol-2-yl)pentane-1-sulfonyl chloride;N-[(2-fluorophenyl)methyl]-4-[(6-methyl-1H-benzimidazol-2-yl)methyl]cyclohexane-1-carboxamide;1-(2-hydroperoxyethyl)-4-methylcyclohexane;4-methylbenzene-1,2-diamine;1-[4-[(6-methyl-1H-benzimidazol-2-yl)methyl]cyclohexyl]ethanone;uranium;vanadium?
The InChIKey is GQEXLTRNYVQKPS-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H39N5O3S.C23H26FN3O.C17H22N2O.C13H14ClNO4S.C9H18O2.C7H10N2.U.V/c1-20-7-3-4-8-23(20)19-30-28(34)22-11-9-21(10-12-22)17-27-31-25-14-13-24(18-26(25)32-27)33-37(35,36)16-6-2-5-15-29;1-15-6-11-20-21(12-15)27-22(26-20)13-16-7-9-17(10-8-16)23(28)25-14-18-4-2-3-5-19(18)24;1-11-3-8-15-16(9-11)19-17(18-15)10-13-4-6-14(7-5-13)12(2)20;14-20(18,19)9-5-1-4-8-15-12(16)10-6-2-3-7-11(10)13(15)17;1-8-2-4-9(5-3-8)6-7-11-10;1-5-2-3-6(8)7(9)4-5;;/h3-4,7-8,13-14,18,21-22,33H,2,5-6,9-12,15-17,19,29H2,1H3,(H,30,34)(H,31,32);2-6,11-12,16-17H,7-10,13-14H2,1H3,(H,25,28)(H,26,27);3,8-9,13-14H,4-7,10H2,1-2H3,(H,18,19);2-3,6-7H,1,4-5,8-9H2;8-10H,2-7H2,1H3;2-4H,8-9H2,1H3;;.
What are the key properties of 4-[[6-(5-aminopentylsulfonylamino)-1H-benzimidazol-2-yl]methyl]-N-[(2-methylphenyl)methyl]cyclohexane-1-carboxamide;5-(1,3-dioxoisoindol-2-yl)pentane-1-sulfonyl chloride;N-[(2-fluorophenyl)methyl]-4-[(6-methyl-1H-benzimidazol-2-yl)methyl]cyclohexane-1-carboxamide;1-(2-hydroperoxyethyl)-4-methylcyclohexane;4-methylbenzene-1,2-diamine;1-[4-[(6-methyl-1H-benzimidazol-2-yl)methyl]cyclohexyl]ethanone;uranium;vanadium?
4-[[6-(5-aminopentylsulfonylamino)-1H-benzimidazol-2-yl]methyl]-N-[(2-methylphenyl)methyl]cyclohexane-1-carboxamide;5-(1,3-dioxoisoindol-2-yl)pentane-1-sulfonyl chloride;N-[(2-fluorophenyl)methyl]-4-[(6-methyl-1H-benzimidazol-2-yl)methyl]cyclohexane-1-carboxamide;1-(2-hydroperoxyethyl)-4-methylcyclohexane;4-methylbenzene-1,2-diamine;1-[4-[(6-methyl-1H-benzimidazol-2-yl)methyl]cyclohexyl]ethanone;uranium;vanadium has a molecular weight of 2060.74 g/mol, XLogP of 18.76, 29 rotatable bonds, 10 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[[6-(5-aminopentylsulfonylamino)-1H-benzimidazol-2-yl]methyl]-N-[(2-methylphenyl)methyl]cyclohexane-1-carboxamide;5-(1,3-dioxoisoindol-2-yl)pentane-1-sulfonyl chloride;N-[(2-fluorophenyl)methyl]-4-[(6-methyl-1H-benzimidazol-2-yl)methyl]cyclohexane-1-carboxamide;1-(2-hydroperoxyethyl)-4-methylcyclohexane;4-methylbenzene-1,2-diamine;1-[4-[(6-methyl-1H-benzimidazol-2-yl)methyl]cyclohexyl]ethanone;uranium;vanadium is sourced from PubChem (CID 158332714), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).